Develop. Smarter.

SECURE EARLY ACCESS
Enter your details below to be the first to use this powerful AI-assisted tool for CMC Development. You'll get exclusive early access.

By registering you also consent to receive reminder emails and occasional promotional emails of which you can opt out any time.

 

Develop. Smarter.

SECURE EARLY ACCESS
Enter your details below to be the first to use this powerful AI-assisted tool for CMC Development. You'll get exclusive early access.

By registering you also consent to receive reminder emails and occasional promotional emails of which you can opt out any time.

Stop Flying Blind in CMC

See dependencies your Gantt chart hides. Get alerted to risks weeks early. Generate board reports in one click. 

We're building an AI co-pilot to deliver exactly that. For emerging biotech teams heading to their first mAb IND.

Join the priority access list to get early access

Intelligent decision making

Get AI-powered insights that turn complex CMC choices into clear, confident decisions backed by real-time analysis of your project data

Predictive risk management

Spot risks and regulatory roadblocks weeks before they hit, with automated updates that keep your mitigation strategies current

Strategic Timeline Optimization

Map critical dependencies and automatically recalculate project timelines as milestones complete, ensuring you stay on track

Built by CMC Veterans for Biotech Startup Teams

We have worked with biotech companies globally, supporting CMC programs from preclinical development through regulatory approval.

We built CMC Development Partner to solve the orchestration challenges we saw derail timelines again and again.

FAQ

Your Questions Answered

Does it work for BLA?

We're building IND-first, with BLA support planned for later.

Is my proprietary CMC data secure?

Yes. We're designing the platform with pharma-grade data security. Your confidential program data stays protected.

What about other modalities than mAbs?

Currently optimized for mAbs. Templates for multi-specifics, ADCs, and cell and gene therapy coming in future releases.

Does it work for larger biotech firms?

We're focusing on startups and small biotech companies. We offer bespoke development with additional features for larger companies. Contact us if this is of interest.

SECURE EARLY ACCESS
Enter your details below to be the first to use this powerful AI-assisted tool for CMC Development. You'll get exclusive early access.

By registering you also consent to receive reminder emails and occasional promotional emails of which you can opt out any time.

SECURE EARLY ACCESS
Enter your details below to be the first to use this powerful AI-assisted tool for CMC Development. You'll get exclusive early access.

By registering you also consent to receive reminder emails and occasional promotional emails of which you can opt out any time.

Powered by